Altre lingue Integrated BioPharma, Inc.

Azioni

INBP

US45811V1052

Mercato chiuso - OTC Markets Altri mercati azionari 17:04:38 09/05/2024			Variaz. 5gg	Var. 1 gen.
0,2182 ^USD	+20,82%		+14,48%	-11,01%

10/05	Integrated BioPharma, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 marzo 2024	CI
12/02	Integrated BioPharma, Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	10/05
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	12/02
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	09/11
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	15/09/23
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	15/09/23
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	11/05/23
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)	21/03/23
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President	21/03/23
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement	17/03/23
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/02/23
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	10/02/23
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	28/11/22
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	28/11/22
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/11/22
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	10/11/22
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	24/10/22
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)	13/09/22
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	13/09/22
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)	15/07/22
Integrated BioPharma : Announces Change in Directors - Form 8-K	21/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Integrated BioPharma, Inc.

Azioni

INBP

US45811V1052

Altre lingue

Filtri